The global precision psychiatry market is emerging as one of the most transformative segments within the broader mental health and life sciences landscape. Precision psychiatry focuses on tailoring psychiatric treatments based on an individual’s genetic, biological, behavioral, and environmental profile, moving away from the traditional trial-and-error approach to mental health care. By integrating genomics, biomarkers, advanced diagnostics, and data analytics, precision psychiatry aims to improve treatment outcomes, reduce adverse drug reactions, and enhance overall patient quality of life. As mental health disorders continue to rise worldwide, healthcare systems are increasingly prioritizing personalized approaches, positioning precision psychiatry as a critical solution for modern psychiatric care.

Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86888

Market Size and Growth
The global precision psychiatry market size was valued at US$ 0.9 Bn in 2024 and is projected to reach US$ 4.2 Bn by 2035, expanding at a robust CAGR of 14.2% from 2025 to 2035. This strong growth trajectory reflects rising investments in genomic research, increasing adoption of pharmacogenomic testing, and growing awareness among clinicians and patients regarding personalized mental health therapies. The market’s expansion is further supported by technological advancements in sequencing, bioinformatics, and artificial intelligence, which are making precision-based psychiatric tools more accessible and clinically relevant across healthcare settings.

Market Segmentation
The precision psychiatry market can be segmented based on technology, application, end user, and disorder type. By technology, the market includes genomics, proteomics, metabolomics, neuroimaging, and data analytics platforms. Genomic testing and pharmacogenomics currently dominate the segment due to their proven role in predicting drug response and minimizing side effects. By application, the market covers major depressive disorder, bipolar disorder, schizophrenia, anxiety disorders, ADHD, and other neuropsychiatric conditions. Among end users, hospitals, diagnostic laboratories, academic research institutes, and specialized mental health clinics represent key contributors, with diagnostic laboratories holding a significant share due to increased demand for genetic and biomarker-based tests.

Regional Analysis
Regionally, North America leads the global precision psychiatry market, driven by advanced healthcare infrastructure, strong R&D funding, and high adoption of genetic testing in clinical practice. The United States, in particular, benefits from favorable reimbursement trends and the presence of major market players. Europe follows closely, supported by growing mental health awareness, government initiatives, and expanding genomic research programs. The Asia Pacific region is expected to witness the fastest growth over the forecast period, fueled by rising mental health burden, increasing healthcare expenditure, expanding diagnostic capabilities, and growing acceptance of personalized medicine in countries such as China, India, Japan, and South Korea. Latin America and the Middle East & Africa are gradually gaining traction as awareness and access improve.

Competitive Landscape
The global precision psychiatry market is moderately competitive, with several established and emerging players driving innovation. Leading manufacturers include Labcorp, Myriad Genetics, Inc., TruGenomix, Inc., GeneDx, LLC, Genomind, CNSDose, MedGenome, GeneHealth Global Research & Diagnostics, Quest Diagnostics Incorporated, Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., QIAGEN, Thermo Fisher Scientific Inc., and Fulgent Genetics. These companies focus on product innovation, strategic partnerships, acquisitions, and expansion of diagnostic portfolios to strengthen their market presence.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453